A. Stewart Campbell
Chief Executive Officer at Axial Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Daniel Wolfe | M | 47 |
Synglyco, Inc.
 Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY. | - |
| Ronald Renaud | M | 55 |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 7 years |
| Sarkis K. Mazmanian | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| James Blair | M | 84 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Richard H. Aldrich | M | 69 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Nora Frey | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 3 years |
| Sarah J. Meibusch | F | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 3 years |
| Jeffrey E. Young | M | 51 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Eric Forquenot de la Fortelle | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 5 years |
| Sakae Asanuma | M | 57 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Makoto Ohori | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Scott Brun | M | 56 |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 4 years |
| Chris Meyer | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Steven Opal | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
| Federico Bolognani | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David H. Donabedian | M | - |
Axial Therapeutics, Inc.
Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | 5 years |
| Steven Wood | M | - |
Queen's University
| 6 years |
| David S. Wai | M | 52 |
Queen's University
| 5 years |
| Chris Gear | M | - |
Queen's University
| 7 years |
| Michael T. R. List | M | 53 |
Queen's University
| 8 years |
| Rob Barbara | M | - |
Queen's University
| 4 years |
| Adam Shah | M | - |
Queen's University
| 7 years |
| Mike Nazwaski | M | - |
Queen's University
| 5 years |
| Peter Heusel | M | - |
Queen's University
| 7 years |
| Peter Williams | M | - |
Queen's University
| 4 years |
| Joshua P. Kleban | M | 53 |
Queen's University
| 4 years |
| Heather Allen | F | 56 |
Queen's University
| 4 years |
| Mark Armour | M | 53 |
Queen's University
| 4 years |
| Jzaneen Lalani | F | 51 |
Queen's University
| 4 years |
| Chris Naprawa | M | - |
Queen's University
| 4 years |
| Ann Driscoll | F | - |
Queen's University
| 4 years |
| Patrick Keefe | M | - |
Queen's University
| 4 years |
| Ravi Dinesh Bhat | M | - |
Queen's University
| 4 years |
| Zahrein bin Mohammed Redza | M | 59 |
Queen's University
| 1 years |
| Yuet Pun Cheung | M | 52 |
Queen's University
| 4 years |
| Sean McKinley | M | 51 |
Queen's University
| 4 years |
| Rafael Wagner | M | 50 |
Queen's University
| 4 years |
| Brent Roland | M | - |
Queen's University
| 4 years |
| Brad Elberg | M | - |
Queen's University
| 4 years |
| Alex Baniczky | M | - |
Queen's University
| 4 years |
| Daniel Kim | M | - |
Queen's University
| 2 years |
| Stacy Petriuk | F | - |
Queen's University
| 4 years |
| Marc McQuillen | M | - |
Queen's University
| 4 years |
| Patrice Walch-Watson | F | - |
Queen's University
| 3 years |
| Mike Dilworth | M | - |
Queen's University
| 4 years |
| Oliver Blum | M | - |
Queen's University
| 5 years |
| Kathryn McLaughlin | F | 52 |
Queen's University
| 4 years |
| Kevin Reid | M | 52 |
Queen's University
| 4 years |
| Eric Brouwer | M | - |
Queen's University
| 4 years |
| Erin Crowe | F | 53 |
Queen's University
| 4 years |
| Shuang Xie | M | 55 |
Queen's University
| 4 years |
| Derek Mendham | M | - |
Queen's University
| 4 years |
| Chand Sooran | M | - |
Queen's University
| 2 years |
| Stuart John Campbell | M | - |
Queen's University
| 4 years |
| Nigel A. Lewis | M | - |
Queen's University
| 4 years |
| Martin Pradier | M | - |
Queen's University
| 2 years |
| Hing Keung Mak | M | 61 |
Queen's University
| 4 years |
| Mason Granger | M | - |
Queen's University
| 5 years |
| James G. McVicar | M | 58 |
Queen's University
| 4 years |
| Duncan Middlemiss | M | 62 |
Queen's University
| 4 years |
| Stu Kedwell | M | - |
Queen's University
| 5 years |
| Stephen Thompson | M | 55 |
Queen's University
| 4 years |
| David S. Finch | M | - |
Queen's University
| 4 years |
| Tamara Steinberg | F | - |
Queen's University
| 3 years |
| Jacques Simoneau | M | 66 |
Queen's University
| 3 years |
| Jason Gerald Capello | M | 51 |
Queen's University
| 4 years |
| Mark Selby | M | 58 |
Queen's University
| 4 years |
| Robert Pollock | M | 54 |
Queen's University
| 4 years |
| Steve Parsons | M | - |
Queen's University
| 4 years |
| Guy Barry Caplan | M | - |
Queen's University
| 2 years |
| Jeff Elliott | M | - |
Queen's University
| 4 years |
| Amy Glading | F | - |
Queen's University
| 4 years |
| Myles William Zyblock | M | - |
Queen's University
| 3 years |
| Carolyn Susan Dennis | F | - |
Queen's University
| 4 years |
| Dominique Barker | F | 52 |
Queen's University
| 5 years |
| Joe Timlin | M | - |
Queen's University
| 4 years |
| Paul McHugh | M | - |
St. Francis Xavier University
| 4 years |
| Malcolm Stephen White | M | - |
Queen's University
| 4 years |
| Shane Maine | M | - |
Queen's University
| 4 years |
| Elizabeth A. McLemore | F | - |
Queen's University
| 4 years |
| Kirby Michael O'Connor | M | - |
Queen's University
| 2 years |
| Leslie F. Kende | M | - |
Queen's University
| 4 years |
| John Donelson | M | 59 |
Queen's University
| 2 years |
| Patrick M. Boucher | M | - |
Queen's University
| 3 years |
| Jonathan William Hunter | M | - |
Queen's University
| 4 years |
| Anna Ladd-Kruger | F | 53 |
Queen's University
| 1 years |
| Sheila Elizabeth Norman | F | - |
Queen's University
| 4 years |
| Shannon C. Shaw | F | 53 |
Queen's University
| 4 years |
| Tim Sun | M | 62 |
Queen's University
| 3 years |
| Brent Harris | M | - |
Queen's University
| 4 years |
| James A. Mott | M | - |
Queen's University
| 3 years |
| Zohrab Mawani | M | - |
Queen's University
| 4 years |
| Janet Reid | F | - |
Queen's University
| 4 years |
| Gordon S. Bakarich | M | - |
Queen's University
| 4 years |
| Yafan Huang | M | - |
Queen's University
| 3 years |
| Hyong-Gue Bang | M | 50 |
Queen's University
| 4 years |
| Ian Prittie | M | - |
Queen's University
| 4 years |
| Lars G. Leckie | M | - |
Queen's University
| 4 years |
| Nils Voermann | M | - |
Queen's University
| 4 years |
| Jason Macfarlane | M | - |
Queen's University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 84 | 84.00% |
| United States | 16 | 16.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- A. Stewart Campbell
- Personal Network
